Sort   by:  
 Page size 
ProteomicsA microenvironment-inspired synthetic 3D model for pancreatic ductal adenocarcinoma organoids - PDA Matrisome
LFQ analysis of matrisome fractions enriched from 12 murine PDA or PanIN samples (samples 1 - 12) and a normal pancreas pool (samples 13) pooled from 10 pancreata of C57-Bl6 animals. Three independent enrichments have been conducted for each sample with each having had four injections.
ORGANISM(S): Mus musculus (Mouse) 
2021-11-29 | PXD022767 | Pride
Ecm Pdac Cancer Syntheticmatrix 
ProteomicsA microenvironment-inspired synthetic 3D model for pancreatic ductal adenocarcinoma organoids - Pancreas matrisome atlas
LC-MS/MS based analysis of the normal pancreas matrisome from 10 C57-Black6 animals. Matrisome abundance was quantified using a label-free quantification approach.
ORGANISM(S): Mus musculus (Mouse) 
2021-11-29 | PXD022555 | Pride
Ecm Pdac Organoids Syntheticmatrix Pancreas 
ProteomicsA microenvironment-inspired synthetic 3D model for pancreatic ductal adenocarcinoma organoids - IAC Sets
Integrin adhesion complex (IAC) datasets from KPC-1 and iKRAS cells after 3h or 12h of adhesion on a fibronectin pre-coated surface. IACs were isolated using previously established methods and IACs were investigated using LC-MS/MS.
ORGANISM(S): Mus musculus (Mouse) 
2021-11-29 | PXD022487 | Pride
Tumour Organoids Syntheticmatrice Pdac 
ProteomicsA microenvironment-inspired synthetic 3D model for pancreatic ductal adenocarcinoma organoids - CDM Sets
Cell-derived matrix (CDM) datasets from KPC-1 or HPDE cells after seven days of growth.
ORGANISM(S): Homo sapiens (Human) Mus musculus (Mouse) 
2021-11-29 | PXD022509 | Pride
Ecm Pdac Cancer Syntheticmatrix 
ProteomicsA microenvironment-inspired synthetic 3D model for pancreatic ductal adenocarcinoma organoids - 3D PEG-CBF-0.5 MS
LC-MS/MS based analysis of murine PCOs growing in 3D PEG-CBF-0.5 hydrogels for four days.
ORGANISM(S): Mus musculus (Mouse) 
2021-11-29 | PXD022520 | Pride
Ecm Pdac Organoids Syntheticmatrix 
UnknownComprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.
Not available
S-EPMC4914477 | biostudies-literature
UnknownAssociation Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.
Not available
S-EPMC4621257 | biostudies-literature
UnknownNeurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study.
Not available
S-EPMC12829746 | biostudies-literature
UnknownWHO O2CoV2: oxygen requirements and respiratory support in patients with COVID-19 in low-and-middle income countries-protocol for a multicountry, prospective, observational cohort study.
Not available
S-EPMC10441039 | biostudies-literature
UnknownLipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Not available
S-EPMC8822604 | biostudies-literature
Sort   by:  
 Page size